NCT05644145View on ClinicalTrials.gov

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

NAActive, not recruitingINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

September 7, 2023

Study Completion Date

July 30, 2025

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Serological study after yellow fever vaccination

It is a serological survey of the cohort of children who participated in the preliminary investigation and seroconverted after vaccination against yellow fever.

Trial Locations (3)

Unknown

SAMIC Eldorado Hospital, Eldorado

SAMIC Obera Hospital, Oberá

Favoloro Hospital, Posadas

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Pan American Health Organization

OTHER

lead

Ministry of Public Health, Argentina

OTHER_GOV